QPS collaborates to advance biologics bioanalysis solution

By Melissa Fassbender contact

- Last updated on GMT

The BioBA solution includes ready-to-use sample preparation kits. (Image: iStock/barbol88)
The BioBA solution includes ready-to-use sample preparation kits. (Image: iStock/barbol88)

Related tags: Molecule, Contract research organization

The new collaboration aims to advance a workflow solution for biologics quantification.

SCIEX, a life science analytical technology company and QPS Holdings, a full-service Contract Research Organization (CRO), announced the collaboration yesterday.

SCIEX provides support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry to clients focusing on basic research, drug discovery and development, food and environmental testing, forensics, and clinical research.

The new joint venture will work to advance Hybrid LBA –LCMS, a workflow for routine biologics quantification. Per the agreement, QPS Holdings will deploy SCIEX’s BioBA Solution, wich the companies describes as “the first end-to-end and most complete solution for bioanalysis of biologics​.”

According to the company, as the industry continues to develop more large molecule therapies, new challenges will continue to arise, including characterizing and quantifying large molecules such as peptides, proteins, monoclonal antibodies, oligonucleotides, and antibody drug conjugates in complex biological matrices. 

The BioBA solution includes ready-to-use sample preparation kits, a fully automated liquid sample handler, a LC component, and a QTRAP MS System with software for performing bioanalytical studies designed to support CFR 21 part 11 compliance.

The integrated BioBA solution enables scientists transitioning from traditional small molecule bioanalysis to biologics, to generate robust, reproducible and high-quality data​,” said Farzana Azam, Senior Director of Pharma/CRO Business at SCIEX. “BioBA empowers scientists to turn the complexities of biologics bioanalysis into a simple process for both experts and non-experts, making the transition from small to large molecules easier than you think​.”

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us

Products

View more

Webinars